Intensified chemotherapy and simultaneous treatment with heparin in outpatients with pancreatic cancer – the CONKO 004 pilot trial

BACKGROUND: Advanced pancreatic cancer (APC), beside its high mortality, causes the highest rates of venous thromboembolic events (VTE). Enoxaparin, a low molecular weight heparin (LMWH), is effective in prevention and treatment of VTE. Some small studies indicated that this benefit might extend to...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Pelzer, Uwe, Hilbig, Andreas, Stieler, Jens M, Bahra, Marcus, Sinn, Marianne, Gebauer, Bernhard, Dörken, Bernd, Riess, Hanno
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2014
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3994651/
https://ncbi.nlm.nih.gov/pubmed/24641937
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-204
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak